Healthcare & Life Sciences Private Equity Deal Tracker: WindRose Acquires Ganse Apothecary

McGuireWoods LLP
Contact

WindRose Health Investors has acquired Ganse Apothecary, according to a news release.

Ganse, based in Lancaster, Pa., is a closed-door, long-term care and specialty pharmacy. Founded in 1971, the pharmacy supports patients suffering from severe and persistent mental illness and intellectual and developmental disabilities.

WindRose, based in New York, pursues control equity investments in healthcare companies. Founded in 2000, the firm invests in a broad range of industry segments, including outsourced services to payors and health systems, technology-enabled services, healthcare providers and value-added distribution.

Terms of the transaction were not disclosed.

WindRose is merging Ganse with Terrapin Pharmacy, an existing portfolio company. Based in Annapolis, Md., Terrapin is a specialized pharmacy primarily serving individuals diagnosed with severe and persistent mental illnesses in the Mid-Atlantic region.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© McGuireWoods LLP | Attorney Advertising

Written by:

McGuireWoods LLP
Contact
more
less

PUBLISH YOUR CONTENT ON JD SUPRA NOW

  • Increased visibility
  • Actionable analytics
  • Ongoing guidance

McGuireWoods LLP on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide